Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mogun

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Gastroenterology|June 1, 1997
Concurrent use of antiulcerative agentsJ Monette, H Mogun, R L Bohn, et al.
JAMA|June 24, 2000
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patientsP S Wang, D H Solomon, H Mogun, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 10, 2008
The relation between bisphosphonate use and non-union of fractures of the humerus in older adultsD H Solomon, M C Hochberg, H Mogun, et al.
Clinical Pharmacology and Therapeutics|April 22, 2011
Antidepressants and fracture risk in older adults: a comparative safety analysisJ J Gagne, A R Patrick, H Mogun, et al.
Journal of the American Geriatrics Society|June 12, 1999
Definition of race and ethnicity in older people in Medicare and MedicaidC X Pan, R J Glynn, H Mogun, et al.
Journal of General Internal Medicine|May 26, 1999
Nonoccupational risk factors for carpal tunnel syndromeD H Solomon, J N Katz, R Bohn, et al.
Journal of the American Geriatrics Society|February 15, 2002
Zolpidem use and hip fractures in older peopleP S Wang, R L Bohn, R J Glynn, et al.
American Heart Journal|October 28, 1999
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)E L Knight, R J Glynn, K M McIntyre, et al.
The American Journal of Psychiatry|June 1, 2001
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fractureP S Wang, R L Bohn, R J Glynn, et al.
JAMA|December 13, 1995
Increased incidence of levodopa therapy following metoclopramide useJ Avorn, J H Gurwitz, R L Bohn, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Gastroenterology|June 1, 1997
Concurrent use of antiulcerative agentsJ Monette, H Mogun, R L Bohn, et al.
JAMA|June 24, 2000
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patientsP S Wang, D H Solomon, H Mogun, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 10, 2008
The relation between bisphosphonate use and non-union of fractures of the humerus in older adultsD H Solomon, M C Hochberg, H Mogun, et al.
Clinical Pharmacology and Therapeutics|April 22, 2011
Antidepressants and fracture risk in older adults: a comparative safety analysisJ J Gagne, A R Patrick, H Mogun, et al.
Journal of the American Geriatrics Society|June 12, 1999
Definition of race and ethnicity in older people in Medicare and MedicaidC X Pan, R J Glynn, H Mogun, et al.
Journal of General Internal Medicine|May 26, 1999
Nonoccupational risk factors for carpal tunnel syndromeD H Solomon, J N Katz, R Bohn, et al.
Journal of the American Geriatrics Society|February 15, 2002
Zolpidem use and hip fractures in older peopleP S Wang, R L Bohn, R J Glynn, et al.
American Heart Journal|October 28, 1999
Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)E L Knight, R J Glynn, K M McIntyre, et al.
The American Journal of Psychiatry|June 1, 2001
Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fractureP S Wang, R L Bohn, R J Glynn, et al.
JAMA|December 13, 1995
Increased incidence of levodopa therapy following metoclopramide useJ Avorn, J H Gurwitz, R L Bohn, et al.
Pageof 3